Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database

被引：0
|
作者：
Revol, B. [1 ]
Jullian-Desayes, I. [2 ]
Cracowski, J. L. [3 ]
Tamisier, R. [2 ]
Mallaret, M. [1 ]
Joyeux-Faure, M. [2 ]
Pepin, J. L. [2 ]
机构：
[1] Grenoble Alpes Univ Hosp, Pharmacovigilance Dept, Grenoble, France
[2] Grenoble Alpes Univ, HP2 Lab, INSERM, U1042, Grenoble, France
[3] Grenoble Alpes Univ Hosp, Dept Clin Pharmacol, Grenoble, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-006
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [31] Calcitonin gene-related peptide-targeting drugs and Raynaud's phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database
    Gerard, Alexandre O.
    Merino, Diane
    Van Obberghen, Elise K.
    Rocher, Fanny
    Destere, Alexandre
    Lanteri-Minet, Michel
    Drici, Milou-Daniel
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [32] Obstructive Sleep Apnea Syndrome Diagnosis using HRV Signal Processing
    Ghafourian, Mandana Sadat
    Tabatabaee, Pargol Sadat
    Noori, Amin
    2019 27TH IRANIAN CONFERENCE ON ELECTRICAL ENGINEERING (ICEE 2019), 2019, : 1819 - 1824
  • [33] Safety of Biologic Therapies for Severe Asthma: An Analysis of Adverse Reactions Reported in the WHO Pharmacovigilance Database
    Cutroneo, P. M.
    Arzenton, E.
    Furci, F.
    Bulzomi, M.
    Caminati, M.
    Senna, G.
    Moretti, U.
    Trifiro, G.
    DRUG SAFETY, 2022, 45 (10) : 1160 - 1161
  • [34] Seasonal differences in obstructive sleep apnea severity. Results from the European Sleep Apnea Database (ESADA)
    Staats, R.
    Grote, L.
    Saaresranta, T.
    Gunduz, C.
    Pataka, A.
    Riha, R.
    Marrone, O.
    Ryan, S.
    Schiza, S. E.
    Bonsignore, M.
    Verbraecken, J.
    Hedner, J.
    JOURNAL OF SLEEP RESEARCH, 2018, 27
  • [35] Kounis Syndrome: An analysis of spontaneous reports from international pharmacovigilance database
    Renda, Francesca
    Landoni, Giovanni
    Trotta, Francesco
    Piras, Desiderio
    Finco, Gabriele
    Felicetti, Patrizia
    Pimpinella, Giuseppe
    Pani, Luca
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 203 : 217 - 220
  • [36] Safety Signal of Dulaglutide and the Risk of Dysgeusia: Evidence From Pharmacovigilance Data
    Alakeel, A.
    Fouda, M.
    Alamri, R.
    Alomair, A.
    DRUG SAFETY, 2021, 44 (12) : 1437 - 1437
  • [37] Beyond sleep apnea syndrome: lessons from other sleep disorders
    Ferini-Strambi, L.
    JOURNAL OF SLEEP RESEARCH, 2008, 17 : 57 - 57
  • [38] Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
    Paola Maria Cutroneo
    Elena Arzenton
    Fabiana Furci
    Fabio Scapini
    Maria Bulzomì
    Nicoletta Luxi
    Marco Caminati
    Gianenrico Senna
    Ugo Moretti
    Gianluca Trifirò
    BioDrugs, 2024, 38 : 425 - 448
  • [39] Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine
    Svedmyr, Sven
    Hedner, Jan
    Bonsignore, Maria Rosaria
    Lombardi, Carolina
    Parati, Gianfranco
    Ludka, Ondrej
    Zou, Ding
    Grote, Ludger
    JOURNAL OF SLEEP RESEARCH, 2023, 32 (04)
  • [40] Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
    Cutroneo, Paola Maria
    Arzenton, Elena
    Furci, Fabiana
    Scapini, Fabio
    Bulzomi, Maria
    Luxi, Nicoletta
    Caminati, Marco
    Senna, Gianenrico
    Moretti, Ugo
    Trifiro, Gianluca
    BIODRUGS, 2024, 38 (03) : 425 - 448
12345